Various molds and pieces of eyeballs lie on a workbench atSilicone Arts Laboratories LLC, which manufactures dermaflage, asilicone-based cosmetic scar filler.
(Photo: Lance Murphey)
Silicone Arts Laboratories’ new product goes mass-market
By Andy Meek
Earlier in Matt Singer’s career, he used the special effects wizardry of Hollywood toentertain.Today, he’s part of a commercial enterprise with a lab and workspace in DowntownMemphis that draws on that same body of knowledge to try and improve lives.Singer, a former designer of monsters andmakeup effects for films and TV shows suchas “X-Files” and “Buffy the Vampire Slayer,”is the director of research and developmentat Silicone Arts Laboratories.He’s worked in Memphis for several yearsand once focused primarily on sculpting aparticular prosthetic device – an artificialeye. With help from Southern Growth Ventures,another Memphis entity and one that’s partof a joint venture with Silicone Arts, theenterprise has been slowly moving into moremass-market territory thanks in part to oneof its newest products.Dermaflage is Silicone Arts’ “topical perfecting filler” that consumers can buy and then apply onto things like scars and wrinkles. It will conceal them for up to 36 hours and is quick enough to apply that the company talks about it being able to get incorporated into, forexample, the makeup routines of its female customers.Kits of the product are stacked in columns inside the entity’s workspace at G.E. Patterson Avenue and Tennessee Street. Also there, colorists are at work perfecting the shades of therange of ethnic skin tones that are available, and benches are piled with various brushes,sculpting tools and small artificial skin creations, among other things.It is a hive of activity that may be getting a lot bigger soon.“This is where the orders come in … and you just can’t be in a better place for distribution,”said CEOOscar Atkinson, leading a tour of the space.
Special Effect - Memphis Daily Newshttp://www.memphisdailynews.com/news/2012/jun/1/special-ef...1 of 25/31/12 3:15 PM